Impax Lab Cash Flow - Annual (NASDAQ:IPXL)

Add to My Stocks
$20.45 $0.6 (2.85%) IPXL stock closing price Mar 19, 2018 (Closing)

The financial analysis of IPXL requires an investor to check the cash flows for Impax Lab. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Impax Lab profits one has to check the income statement and for Impax Lab debt one has to check the balance sheet. This statement can tell if a company is running out of money while still being profitable and is useful in Impax Lab stock analysis. Impax Lab had a negative net income cash flow of $-472.03M for the latest 2016. This report is very useful in measuring the short term viability of a company. Impax Lab saw a outflow of $-627.09M from investing activities for 2016.

View details of Impax Lab cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011201020092008
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow88.34M68.63M34.02M36M89.6M18.82M121.32M36.14M47.58M
Net Increase (Decrease) in Assets Liabilities-2.43M-70.18M-76.23M-11.04M32.55M-98.92M82.19M-97.25M-1.36M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net460.71M34.47M17.66M23.72M-71.82M20.96M-204.17M2.89M-0.35M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-48.04M-25.19M-29.91M-32.78M-66.9M-30.52M-16.26M-13.66M-25.86M
Acquisition Disposition of Subsidiaires-585.8M-691.34M-------
Increase (Decrease) in Investments-4.75M195.31M26.31M-71.1M85.87M15.48M-197.36M-7.36M58.19M
Other Cash Inflow (Outflow) from Investment Activities11.5M53.69M-13M-12M-104.76M---0.75M-
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares9.23M99.79M11.09M8.21M12.61M14.77M17.72M5.11M-
Issuance (Repayment) of Debt Securities395M600M------12.88M-65.23M
Increase (Decrease) in Bank & Other Borrowings---------
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities-12.45M-178.4M3.31M-4.7M6.53M6.17M--
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash--0.29M-0.36M-0.56M-----
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year340.35M214.87M184.61M142.16M104.41M91.79M31.77M69.27M37.46M
Cash & Equivalents at Year End180.13M340.35M214.87M184.61M142.16M104.41M91.79M31.77M69.27M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Impax Lab stock price history and Impax Lab stock comparison chart inevitably reflect its cash flow situation.

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Impax Lab is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Impax Lab stock price movement.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a positive value of $74.59M for IPXL.
  • Cash from investing stood at a negative value of $-627.09M for IPXL stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $391.78M for Impax Lab.

Key Financial Ratios For Impax Lab Cash Flow

FCF margin

Annual Cash Flow Statements For Impax Laboratories Inc Peers

Akorn cash flow, Lipocine cash flow, Novartis cash flow, Supernus Pharma cash flow, Valeant cash flow